Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society
Authors:
- 28 March 2021
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (11) , 2435-2444
Abstract
Purpose The standard treatment of hypothyroidism is levothyroxine (LT4), which is available as tablets or soft-gel capsules in Denmark. This study aimed to investigate Danish endocrinologists’ use of thyroid hormones in hypothyroid and euthyroid patients. Methods An e-mail with an invitation to participate in an online survey investigating practices about substitution with thyroid hormones was sent to all members of the Danish Endocrine Society (DES). Results Out of 488 eligible DES members, a total of 152 (31.2%) respondents were included in the analysis. The majority (94.1%) of responding DES members use LT4 as the treatment of choice. Other treatment options for hypothyroidism are also used, as 58.6% prescribe combination therapy with liothyronine (LT3) + LT4 in their clinical practice. LT4 + LT3 combination is preferred in patients with persistent symptoms of hypothyroidism despite biochemical euthyroidism on LT4 treatment. Over half of the respondents answered that thyroid hormone therapy is never indicated for euthyroid patients, but 42.1% will consider it for euthyroid infertile women with high antibody levels. In various conditions that could interfere with the absorption of LT4, most responding Danish endocrinologists prefer tablets and do not expect a significant difference when switching from one type of tablet formulation to another. Conclusion The treatment of choice for hypothyroidism is LT4. Combination therapy with LT4 + LT3 is considered for patients with persistent symptoms. Even in the presence of conditions affecting bioavailability, responding Danish endocrinologists prefer LT4 tablets rather than newer LT4 formulations, such as soft-gel capsules.Keywords
Funding Information
- IBSA Institute Biochimique SA
- Danish Medicine Agency
- The Region of Southern Denmark
This publication has 28 references indexed in Scilit:
- Increased Psychiatric Morbidity Before and After the Diagnosis of Hypothyroidism: A Nationwide Register StudyThyroid®, 2014
- The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2014
- Desiccated Thyroid Extract Compared With Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-Blind, Crossover StudyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Excess Mortality in Patients Diagnosed With Hypothyroidism: A Nationwide Cohort Study of Singletons and TwinsThe Journal of Clinical Endocrinology & Metabolism, 2013
- 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of HypothyroidismEuropean Thyroid Journal, 2012
- Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt?European Journal of Epidemiology, 2011
- A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the populationClinical Endocrinology, 2011
- The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapyClinical Endocrinology, 2008
- An Increased Incidence of Overt Hypothyroidism after Iodine Fortification of Salt in Denmark: A Prospective Population StudyThe Journal of Clinical Endocrinology & Metabolism, 2007
- Management of the nontoxic multinodular goitre: A European questionnaire studyClinical Endocrinology, 2000